OraSure Technologies, Inc. Share Price & Technical Analysis

OSUR · $3.79 (+4.99%)

Healthcare / Medical Instruments & Supplies

AI Score 74 · Neutral

$3.79

+4.99%

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid

Price chart

Seasonality

May has 1 positive and 4 negative years (last 5 years shown)

20% return in May, -14% avg return in past 3 year May month.

55% return in 2026, -16% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
2617%14%-3%7%20%55%
2511%-12%-6%-12%-3%7%7%3%-3%-16%-11%0%-35%
24-9%-3%-14%-15%-11%-10%5%0%-4%-5%-7%-8%-81%
2314%13%-3%13%-26%-7%-6%38%-9%-12%40%12%67%
222%-11%-13%-10%-31%-36%15%37%-5%16%14%-6%-29%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 74/100

Neutral · Strong · Exhausted

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of urine samples; and HEMAcollect protein blood collection device. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. It sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, and companion animal, markets. The company was founded in 1987 and is headquartered in Bethlehem, Pennsylvania.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$199.32M

P/E ratio

52W high

$4.03

52W low

$2.08

Volume

11,06,227

Beta

0.89

Related stocks in Healthcare

Frequently asked questions

What is OraSure Technologies, Inc. share price today?
OraSure Technologies, Inc. (OSUR) last traded around $3.79 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does OSUR have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for OSUR. Download the app for real-time alerts.
How can I analyze OraSure Technologies, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro